BRIEF-Valeant CEO says will get back to acquisitions - but not next year
Dec 15 (Reuters) - Valeant Pharmaceuticals International Inc
* CEO says will get back to acquisitions, but not next year, when it will focus on paying down debt instead - CNBC
* CEO says will spend 7 to 8 percent of sales on research and development in 2016 - about half the level of typical big pharma companies and up from previous spending - CNBC
* CEO says will spend $400 to $500 million on R&D (Reporting By Caroline Humer)
© Thomson Reuters 2017 All rights reserved.